Trial Profile
A Phase 1 Study of Topotecan Liposomes Injection (TLI) in Subjects With Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Nov 2020
Price :
$35
*
At a glance
- Drugs Topotecan (Primary)
- Indications Ovarian cancer; Small cell lung cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Spectrum Pharmaceuticals; Talon Therapeutics
- 11 Nov 2020 Status changed from active, no longer recruiting to completed.
- 16 Oct 2017 Planned End Date changed from 1 Dec 2015 to 1 Dec 2018.
- 16 Oct 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2018.